Dong-E-E-Jiao Co., Ltd. — Investor Relations & Filings
Dong-E-E-Jiao Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine, with a primary focus on E-Jiao (donkey-hide gelatin) and its derivative products. The company’s core portfolio includes E-Jiao blocks, Fufang Ejiao Jiang, and various health supplements designed for blood nourishment and overall wellness. Recognized for its commitment to quality and heritage, the firm integrates a complete industrial chain encompassing donkey breeding, processing technology, and pharmaceutical manufacturing. It leverages modern scientific research to standardize traditional production methods, ensuring product efficacy and safety. Serving a broad consumer base seeking natural health solutions, the company maintains a dominant position in the tonic market through its focus on brand integrity and the preservation of national intangible cultural heritage.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2019年第三季度报告全文 | 2019-10-30 | Chinese | |
| 2019年前三季度业绩预告 | 2019-10-14 | Chinese | |
| 关于回购股份的进展公告 | 2019-10-09 | Chinese | |
| 关于回购股份的进展公告 | 2019-09-03 | Chinese | |
| 2019年半年度报告 | 2019-08-21 | Chinese | |
| 关于会计政策变更的公告 | 2019-08-21 | Chinese |
Browse filings by year
27 years- 2026 23 filings
- 2025 149 filings
- 2024 103 filings
- 2023 81 filings
- 2022 89 filings
- 2021 67 filings
- 2020 75 filings
- 2019 70 filings
- 2018 75 filings
- 2017 41 filings
- 2016 47 filings
- 2015 51 filings
- 2014 59 filings
- 2013 52 filings
- 2012 56 filings
- 2011 44 filings
- 2010 66 filings
- 2009 62 filings
- 2008 52 filings
- 2007 79 filings
- 2006 45 filings
- 2005 31 filings
- 2004 33 filings
- 2003 22 filings
- 2002 22 filings
- 2001 2 filings
- 1996 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2019
15 filings
| |||||
| 42072753 | 2019年第三季度报告全文 | 2019-10-30 | Chinese | ||
| 42072695 | 2019年前三季度业绩预告 | 2019-10-14 | Chinese | ||
| 42072677 | 关于回购股份的进展公告 | 2019-10-09 | Chinese | ||
| 42072673 | 关于回购股份的进展公告 | 2019-09-03 | Chinese | ||
| 42072655 | 2019年半年度报告 | 2019-08-21 | Chinese | ||
| 42072523 | 关于会计政策变更的公告 | 2019-08-21 | Chinese | ||
| 42072511 | 第九届董事会第七次会议决议公告 | 2019-08-21 | Chinese | ||
| 42072492 | 2019年半年度报告摘要 | 2019-08-21 | Chinese | ||
| 42072480 | 独立董事对第九届董事会第七次会议相关事项发表的独立意见 | 2019-08-21 | Chinese | ||
| 42072470 | 关于增补董事的公告 | 2019-08-21 | Chinese | ||
| 42072459 | 第九届监事会第七次会议决议公告 | 2019-08-21 | Chinese | ||
| 42072449 | 2018年度权益分派实施公告 | 2019-08-07 | Chinese | ||
| 42072440 | 关于回购股份的进展公告 | 2019-08-02 | Chinese | ||
| 42072431 | 2019年半年度业绩预告 | 2019-07-14 | Chinese | ||
| 42072419 | 关于董事辞职的公告 | 2019-07-12 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Dong-E-E-Jiao Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53624/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53624 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53624 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53624 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53624}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Dong-E-E-Jiao Co., Ltd. (id: 53624)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.